As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.
With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.
PRODUCT PORTFOLIO
RARE DISEASES
IMMUNOLOGY / NEUROLOGY
Ig VENA
Standard Immunoglobulin for intravenous use
INTENSIVE CARE & TRANSPLANTATION
UMAN ALBUMIN
Human Albumin solution
UMAN BIG
Anti-Hepatits B i.m. Immunoglobulin
VENBIG
Anti-Hepatitis B i.v. Immunoglobulin